Committees, working parties and other groups
The European Medicines Agency (EMA) has seven scientific committees and a number of working parties and related groups which conduct the scientific work of the Agency.
In this section
How the committees work
How EMA's committees adopt an opinion or recommendation, what we publish on outcomes and the committtees' composition
Committee for Medicinal Products for Human Use (CHMP)
EMA's human medicines committee, its composition, members, meetings and agendas and outcomes
Pharmacovigilance Risk Assessment Committee (PRAC)
EMA's safety committee, its composition, members, meetings and agendas and outcomes
Committee for Veterinary Medicinal Products (CVMP)
EMA's veterinary medicines committee, its composition, members, meetings and agendas and outcomes
Committee for Orphan Medicinal Products (COMP)
EMA's orphan medicines committee, its composition, members, meetings and agendas and outcomes
Committee on Herbal Medicinal Products (HMPC)
EMA's herbal medicines committee, its composition, members, meetings and agendas and outcomes
Committee for Advanced Therapies (CAT)
EMA's advanced therapies committee, its composition, members, meetings and agendas and outcomes
Paediatric Committee (PDCO)
EMA's paediatric committee, its composition, members, meetings and agendas and outcomes
Working parties and other groups
Information about the working parties that advise EMA's scientific committees on issues relating to their fields of expertise